OLAJIDE MASHA: Open Payments
NPI 1457553505 · ROSENBERG, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,027 in 123 payments from 14 companies in 2025. Trend: 2023 $3,289 · 2024 $2,335 · 2025 $3,027
Food & beverage: $2,918Education: $109
| Company | Payments | Amount |
|---|---|---|
| Teva Pharmaceuticals USA, Inc. | 20 | $608 |
| Otsuka America Pharmaceutical, Inc. | 21 | $509 |
| E.R. Squibb & Sons, L.L.C. | 16 | $406 |
| Alkermes, Inc. | 23 | $393 |
| Supernus Pharmaceuticals, Inc. | 7 | $234 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 8 | $208 |
| Axsome Therapeutics, Inc. | 6 | $183 |
| Janssen Pharmaceuticals, Inc | 3 | $170 |
| Neurocrine BioSciences, Inc. | 6 | $126 |
| Corium, LLC | 6 | $59 |
Products named: COBENFY, ARISTADA, UZEDY, Qelbree, CAPLYTA, AUSTEDO XR, ABILIFY MAINTENA, Auvelity.
Industry payments across TX — which companies pay providers there.
